Pathfinder Bancorp (NASDAQ:PBHC) reported quarterly earnings of $0.50 per share. This is a 61.29 percent increase over earnings of $0.31 per share from the same period last year.
B of A Securities Initiates Coverage On Stoke Therapeutics with Buy Rating, Announces Price Target of $43
B of A Securities analyst Greg Harrison initiates coverage on Stoke Therapeutics (NASDAQ:STOK) with a Buy rating and announces Price Target of $43.